Bleeding is an occurrence stemming from complex interactions encountered in cardiac surgery and is often attributed to the perioperative administration of anti-thrombotic products if inadequate surgical haemostasis is excluded. Very occasionally, bleeding does not fit the norm and the aetiology is not a lack of surgical prolene or an iatrogenic-induced coagulopathy. Patients who present for car...

The use of ventricular assist devices has expanded significantly since their approval by the Food and Drug Administration in the United States in 1994. In addition to this, the prevalence of heart failure continues to increase. We aim to provide an overview of perioperative considerations and management of these patients for non-cardiac surgery. We performed a Medline search for the words "vent...

Following major non-cardiac surgery, large numbers of patients have biochemical evidence perioperative myocardial injury (PMI) associated with increased and long-term morbidity mortality.1 Recent work suggests inflammation is a driver PMI.2 Our research group previously demonstrated right (but not left) ventricular dysfunction in undergoing lung resection hypothesised that an inflammatory to th...

Background and aims: Cardiac surgery patients are at high risk of pressure ulcers. In the present study, we determined the incidence of pressure ulcer in patients who were admitted to open heart cardiac surgery intensive care unit and related risk factors. Methods: With using convenience sampling all the eligible patients who were admitted to Boali cardiac surgery during June to August 2015 we...

The perioperative management of patients at risk for cardiovascular diseases who undergo non-cardiac surgery has been subject of debate over the past few decades and is still of great interest. An adequate perioperative management may modify postoperative mortality and morbidity and may improve the long-term prognosis. The purpose of this review is to examine the present day knowledge regarding...